Kreon

Pancreatin, the active ingredient in Kreon, is a pancreatic enzyme replacement presented as an enteric‑coated capsule for oral use. It treats exocrine pancreatic insufficiency in conditions such as cystic fibrosis, chronic pancreatitis, pancreatic cancer, and after pancreatic resection.

GNH USA supplies Kreon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Kreon, a pancreatic enzyme replacement, is used to manage exocrine pancreatic insufficiency across several gastrointestinal conditions.

- Cystic fibrosis: improves digestion and nutrient absorption by providing essential pancreatic enzymes. - Chronic pancreatitis: alleviates malabsorption symptoms and supports nutritional status. - Pancreatic cancer: assists in digestion when tumor or treatment impairs pancreatic function. - Post‑pancreatic resection: compensates for loss of endogenous enzyme production after surgery.

Kreon may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal discomfort or pain - Flatulence or bloating - Diarrhea or loose stools - Nausea or vomiting - Constipation - Oily or fatty stools (steatorrhea)

Serious or Rare Side Effects: - Severe allergic reactions including anaphylaxis - Pancreatitis or worsening abdominal pain - Intestinal obstruction or blockage - Fecal incontinence - Persistent vomiting or dehydration

When using Kreon, consider the following safety measures.

- Dose Adjustment: follow the prescriber's individualized dosing plan. - Nutritional Monitoring: regularly assess weight, vitamin levels, and stool characteristics. - Allergy Screening: avoid use in patients with known hypersensitivity to porcine proteins. - Meal Timing: take capsules with meals and snacks for optimal enzyme activity. - Concomitant Medications: evaluate potential interactions with acid‑reducing agents. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Kreon can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Proton pump inhibitors or H2 blockers: may reduce enzyme activation by raising gastric pH. - Cholestyramine or other bile‑acid sequestrants: can bind pancreatic enzymes and diminish their effect.

Moderate Interactions (Monitor Closely): - Warfarin: altered vitamin K absorption may affect anticoagulation control. - Oral contraceptives: fat malabsorption could modify hormone levels. - Tetracycline antibiotics: may chelate with enzymes and reduce their activity.